IHE ETF (iShares US Pharmaceutical ETF) is managed by iShares by BlackRock (US) with $969.5M in net assets. IHE expense ratio is 0.38%, holding 60 positions across sectors including Health Care, Unknown, Consumer Staples. Inception date: 2006-05-01.

IHE performance shows a YTD return of 8.61%. The 1-year return is 40.89% and the 5-year return is 9.84%. IHE dividend yield stands at 1.62%, paid quarterly.

IHE top holdings include Johnson & Johnson (21.4%), Eli Lilly and Co. (21.1%), Royalty Pharma (4.8%), Viatris (4.8%), Bristol-Myers Squibb Co. (4.6%). View all IHE holdings, sector breakdown, or dividend history.

IHE can be compared against other funds using the overlap calculator or side-by-side comparison tool. IHE alternatives are available via the screener, along with tax-loss harvesting opportunities.